IP Library › Granted Patent US 9,102,911
Granted Patent B2
US 9,102,911 · App. 13/751,560 · Granted Aug 11, 2015

High density self-contained biological analysis

Inventors: Kirk M. Ririe (Salt Lake City, UT); Gary Clark Kessler (Bountiful, UT); Dave E. Jones (Clearfield, UT); Mark Aaron Poritz (Salt Lake City, UT)
Assignee: BioFire Diagnostics, LLC
C12M33/00B01L3/502738B01L7/52B01L2200/10B01L2200/16B01L2300/044B01L2300/0654B01L2300/0816B01L2300/0864B01L2300/0867B01L2300/1822B01L2400/0481B01L2400/0655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,911
App. No.
13/751,560
Granted
Aug 11, 2015
Kind
B2
Abstract

Devices, containers, and methods are provided for performing biological analysis in a closed environment. Illustrative biological analyses include high density nucleic acid amplification and detection and immuno-PCR.

Claims (13)

1. A container for performing a plurality of reactions on a fluid sample in a closed system comprising:

a high density reaction zone provided in the closed system comprising:

a channel for receiving the fluid sample into the high density reaction zone;

a plurality of high density reaction wells fluidly connected to the channel, each high density reaction well comprising one or more reagents; and

a chemical barrier that minimizes cross-contamination between high density reaction wells upon introduction of the fluid sample to the high density reaction zone, wherein the chemical barrier conditionally releases the one or more reagents into the fluid sample introduced into the high density reaction well by heating or slow release.

2. The container of claim 1 wherein the chemical barrier is a substance that is a solid or gel at storage temperatures, but the substance is a liquid at PCR thermal cycling temperatures.

3. The container of claim 1 further comprising:

a sample injection port for introducing the fluid sample into the container,

a cell lysis zone configured for lysing cells or spores located in the fluid sample, the cell lysis zone fluidly connected to the sample injection port,

a nucleic acid preparation zone fluidly connected to the cell lysis zone, the nucleic acid preparation zone configured for purifying nucleic acids, and

a first-stage reaction zone fluidly connected to the nucleic acid preparation zone and the high density reaction zone, the first stage reaction zone comprising a first-stage reaction blister configured for first-stage amplification of the fluid sample,

wherein the cell lysis zone, the nucleic acid preparation zone, the first stage reaction zone and the high density reaction zone are all provided within the closed system.

4. The container of claim 1 wherein the container comprises a flexible layer that can be pressed against the high density reaction well to seal a portion of the fluid sample in each of the plurality of wells.

Assignments (4)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (RECORDED 3/26/13 AT REEL/FRAME 030091/0893) Recorded Dec 11, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
To: BIOFIRE DIAGNOSTICS, INC.
Reel/Frame 034609/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2014
From: BIOFIRE DEFENSE, LLC
To: BIOFIRE DIAGNOSTICS, LLC
Reel/Frame 033120/0095 →
CERTIFICATE OF CONVERSION Recorded Jun 5, 2014
From: BIOFIRE DIAGNOSTICS, INC.
To: BIOFIRE DEFENSE, LLC
Reel/Frame 033086/0946 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 26, 2013
From: BIOFIRE DIAGNOSTICS, INC.
To: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
Reel/Frame 030091/0893 →
Continuity (2)
Continuation 12515123 · May 15, 2009
Related Publication 20130137172A1 · May 30, 2013